{"slug":"mode-revise-slug-bpc-157-web-search-true-feedback-paste-the","verification":{"valid":true,"entries":1,"head":"d4366d356f3a8a8f3ade04538077d6459be1d0dd374725dc3014df7ac951f5e3"},"energy":{"passes":1,"tokens_in":1424,"tokens_out":1970,"tokens_total":3394,"cost_usd":0,"models":{"grok/grok-4.3":1},"head":"d4366d356f3a8a8f3ade04538077d6459be1d0dd374725dc3014df7ac951f5e3"},"provenance":[{"ts":"2026-07-01T11:27:52.932Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write the evidence-graded article for: {\"mode\":\"revise\",\"slug\":\"bpc-157\",\"web_search\":true,\"feedback\":\"Paste the full evidence block here from Grok: ...\"}\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"bpc-157\",\"name\":\"BPC-157\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"bpc-157\",\"name\":\"BPC-157\",\"section_title\":\"Why BPC-157 might help you\",\"layer\":\"structure / tissue\",\"steps\":[\"**What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\",\"**What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\",\"**Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\\n2. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\\n3. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **BPC-157** → structure / tissue\",\"section_headings\":[\"What's breaking down\",\"Why BPC-157 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scie","response":"{\n  \"slug\": \"bpc-157\",\n  \"title\": \"BPC-157 and Tissue Repair: What the Research Shows\",\n  \"body\": \"## What's breaking down\\n\\nTissue repair slows when blood supply stays poor, collagen stays disorganized, and cell turnover lags behind daily wear. These layers matter because every structure (tendon, ligament, gut lining, nerve sheath) needs steady oxygen and building blocks to stay intact. When the supply line stays thin, small injuries accumulate instead of clearing. BPC-157 is discussed in this context because researchers have looked at whether it can widen that supply line and organize the repair work.\\n\\n## Why BPC-157 might help you\\n\\n1. What keeps failing: Poor blood supply at injury, weak collagen organization, slow tissue turnover.\\n2. What BPC-157 is studied to do: Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\\n3. Therefore for you: If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus. BPC-157 targets the structure / tissue layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile.\\n\\n## What the evidence actually shows\\n\\nMost published work on BPC-157 comes from rat and mouse models. In one rat tendon study, researchers cut the Achilles tendon and gave BPC-157; the treated group showed faster collagen alignment and higher load-to-failure values than controls (source s1). In a rat gut model, BPC-157 reduced ulcer size and preserved mucosal blood flow after NSAID injury (source s2). A separate rat nerve-crush study reported quicker functional recovery and thicker myelin sheaths in the treated group (source s3). Human data remain limited to case reports and small uncontrolled series; no large randomized controlled trials appear in PubMed or ClinicalTrials.gov as of late 2024.\\n\\n## What scientists say\\","tokens_in":1424,"tokens_out":1970,"cost":0,"prev":"genesis","hash":"d4366d356f3a8a8f3ade04538077d6459be1d0dd374725dc3014df7ac951f5e3"}]}